Chemkart India IPO Details
The key details of Chemkart India’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹80.08 Cr |
| Price Range | ₹236 - ₹248 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | BSE |
| Minimum Quantity | 600 |
| Investment (cut-off price) | ₹2,97,600 |
| Pre IPO Promotor Holding | 100.00% |
| Post IPO Promotor Holding | Update soon |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Chemkart India IPO Timelines
The IPO process for Chemkart India includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
07/07/2025
Start Date09/07/2025
End Date11/07/2025
Refund Initiation11/07/2025
Credit of Shares to Demat Ac14/07/2025
Listing DateChemkart India IPO Lot Size
The Chemkart India IPO has a fixed lot size of 600 shares, at an upper price band of ₹248 per share. For retail investors, the minimum and maximum application is 1,200 shares (2 lots) amounting to ₹2,97,600. For HNI investors, the minimum application is 2,400 shares (4 lots) amounting to ₹4,46,400.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 1200 | ₹2,97,600 |
| Retail Maximum | 2 | 1200 | ₹2,97,600 |
| HNI Minimum | 3 | 1800 | ₹4,46,400 |
Chemkart India IPO Subscription Status
The subscription status for Chemkart India IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 13.69x | 5.64x | 1.63x | -- | 5.91x |
IPO Performance on Listing Day
On the listing day (July 14, 2025), Chemkart India made a positive debut on the stock exchange. The stock opened at ₹250, delivering a modest premium of 0.8% over its issue price of ₹248. Throughout the trading session, the stock maintained a steady upward movement, climbing to a high of ₹262 while holding firm at its opening price. The shares concluded their first trading day at ₹259, securing a respectable gain of 4.4% over the issue price, indicating stable investor interest in this specialty chemicals company.
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹250.00 | ₹259.00 | ₹262.00 | ₹250.00 |
Chemkart India IPO Company Financials
Chemkart India reports robust performance in FY2025 with Total Income of ₹205.46 crores, managing expenses at ₹172.86 crores, and achieving a strong PAT (Profit After Tax) of ₹24.26 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2022 | ₹87.43 | ₹80.11 | ₹5.48 |
| FY 2023 | ₹131.69 | ₹121.17 | ₹7.66 |
| FY 2024 | ₹132.83 | ₹112.87 | ₹14.52 |
| FY 2025 | ₹205.46 | ₹172.86 | ₹24.26 |
About Company
Incorporated in 2015, Chemkart India Limited is a B2B distributor specializing in premium food and health ingredients, connecting global manufacturers with businesses across industries. The company supplies ingredients used in manufacturing dietary supplements, including those for sports nutrition, health, vitamins, and proteins. With a strong emphasis on variety, quality, affordability, and long-term customer relationships, Chemkart enhances supply chain efficiency for its clients.
Operating from a 28,259.16 sq. ft. hygienic facility in Bhiwandi, Mumbai, Chemkart offers grinding, blending, packaging, labeling, and sealing services. Its diverse product portfolio includes amino acids, health supplements, herbal extracts, nucleotides, proteins, sports nutrition ingredients, and vitamins—supporting a wide range of nutritional and wellness applications. As of March 31, 2025, the company employed 40 people.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2015 | Healthcare | Ankit Shailesh Mehta |
Know Before Investing
Chemkart India IPO Strengths
- Chemkart India is a recognized B2B supplier specializing in high-quality food, nutraceutical, and health ingredients, serving as a crucial link between global manufacturers and domestic businesses.
- The company offers products across seven major categories—Amino Acids, Health Supplements, Herbal Extracts, Nucleotides, Proteins, Sports Nutrition, and Vitamins—catering to a wide range of industries and applications.
- Chemkart operates a modern warehousing and processing unit in Bhiwandi, Maharashtra, with blending and grinding capacities of 450 and 540 metric tons per annum, respectively, enabling customized solutions for clients.
- Chemkart sources ingredients from FDA/GMP-approved factories in Europe, the US, and China, ensuring access to premium quality raw materials and compliance with international standards.
- Chemkart emphasizes transparency, tailored solutions, and customer service, helping both startups and established enterprises achieve business goals in a competitive market.
- Chemkart has established enduring partnerships with manufacturers of finished supplements, contributing to recurring business and a stable presence in the fast-growing nutraceutical sector.
Chemkart India IPO Risks
- A significant portion of Chemkart’s supplied materials is imported from China, making the company highly vulnerable to geopolitical tensions, trade restrictions, or supply disruptions that could impact business operations and profitability.
- The business relies on the continuous and timely supply of imported raw materials. Any interruption in global logistics, freight rate spikes, or shipping delays could directly affect operations and earnings.
- The company has experienced negative cash flows previously, which may indicate challenges in managing working capital or sustaining profitability during periods of operational stress.
- Chemkart does not have exclusive supply contracts with its vendors, potentially affecting the consistency and availability of raw materials during periods of high demand or shortages.
- The company faces intense competition from established global ingredient traders, which could pressure margins and challenge market share, especially if competitors offer better terms or pricing.
- Fluctuations in international freight and shipping rates can increase operational costs and impact profitability, especially for a business reliant on imports.
Swot Analysis for Chemkart India IPO
Strengths
Diverse Product Portfolio, Strong Financial Growth, End-to-End Supply Chain Solutions
Weaknesses
B2B Market Dependence, Geographical Concentration, Operational Complexity
Opportunities
Rising Demand for Nutraceuticals, Product Line Diversification, Strategic Partnerships
Threats
Intense Industry Competition, Regulatory Risks, Customer Concentration Risk
Company Details
Chemkart India Limited
Office No. 403/404, 4th Floor, K.L. Accolade, 6th Road, TPS III, Santacruz (East), Mumbai – 400055, Maharashtra, India.
Phone: +91 9136383828
Email: investors@chemkart.com
Website: https://chemkart.com/
IPO Registar Details
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
FAQs
The key objectives of Chemkart India SME IPO are:
- Financing the capital expenditure towards setting up of the Manufacturing Facility through investment in the Wholly-Owned Subsidiary (WOS) Company, Easy Raw Materials Private Limited
- Repayment/prepayment of all or certain of the borrowings availed of by the Company
- General Corporate Purpose
Smart Horizon Capital Advisors Private Limited is the book-running lead managers for the Chemkart India IPO.
Meta Infotech has showcased exceptional growth, with revenue rising 55% and PAT jumping 67% in FY25, reflecting strong business scalability. Impressive profitability metrics like 59% ROE, 49% ROCE, and 16.12% EBITDA margin highlight operational efficiency. Coupled with a low debt-to-equity ratio of 0.32, the company stands well-positioned for sustained growth and investor confidence.
The issue price for the Chemkart India IPO is set between ₹236 to ₹248 per share.
To invest in two lot of Chemkart India IPO, you need ₹2,83,200 at the lower price band (₹236 per share) or ₹2,97,600 at the upper price band (₹248 per share) for a lot size of 1200 shares.
Chemkart India IPO shares are scheduled to be listed on the Bombay Stock Exchange (BSE) on July 14, 2025.
Refund/unblocking of funds for Chemkart India IPO will begin on July 11, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your Chemkart India IPO shares on listing day (July 14, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.